Baidu
map

Clin Oral Investig:正颌手术中静脉注射布洛芬可有效缓解患者术后疼痛

2022-06-10 sunshine MedSci原创

正颌手术是颌面外科的一个标准程序,但是术后剧烈疼痛并不少见,需要有效的干预措施。

正颌手术是颌面外科的一个标准程序,但是术后剧烈疼痛并不少见,需要有效的干预措施。近日,发表于Clin Oral Investig的一项前瞻性、随机、双盲、对照的临床研究评估了布洛芬与双氯芬酸加奥芬那定对正颌手术术后疼痛的镇痛效果。

研究纳入将接受正颌手术的患者,随机分为两组:静脉注射600毫克布洛芬(I组)或75毫克双氯芬酸加30毫克奥芬那定(D组),两组都是每天两次。此外,两组都给予甲硝唑500毫克。抢救性止痛药包括对乙酰氨基酚1000毫克和皮利曲胺7.5毫克,视需要而定。主要终点是在住院期间每天三次记录的数字评分表(NRS)以评估疼痛强度,为期3天。

结果,2019年5月至2020年11月,共入组109名患者(年龄范围,18至61岁),进行了48例双侧矢状劈开截骨术(BSSO)和51例双侧颌骨截骨术(BIMAX)。手术亚组分析发现,与I组相比,BIMAX D组患者术后第三天的平均NRS明显较高(2.73 vs.1.23)(P = 0.015)。此外,随着患者身体质量指数(BMI)的增加,平均NRS(r = 0.517,p = 0.001)也增加。在年龄、性别、住院时间、体重、手术时间、疼痛完全缓解的患者数量、对乙酰氨基酚或皮硝唑摄入量和NRS值之间没有发现差异。此外,试验期间也没有观察到不良事件。

综上所述,该研究结果表明,布洛芬的使用和较低的BMI与术后第三天接受双侧颌骨截骨术的患者疼痛较少有关。因此,外科医生可以选择布洛芬,以便在正颌手术后更有效地缓解患者的疼痛。

原始出处: 

Josip Tomic, et al., Intravenous ibuprofen versus diclofenac plus orphenadrine in orthognathic surgery: a prospective, randomized, double-blind, controlled clinical study. Clin Oral Investig. 2022 May;26(5):4117-4125. doi: 10.1007/s00784-022-04381-5.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2051793, encodeId=53922051e93a4, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Jan 09 23:37:22 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039840, encodeId=36fc20398405c, content=<a href='/topic/show?id=be04632e526' target=_blank style='color:#2F92EE;'>#正颌手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63275, encryptionId=be04632e526, topicName=正颌手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Jun 11 14:37:22 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698382, encodeId=aceb16983820d, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Dec 28 22:37:22 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020707, encodeId=bb182020e07df, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Mon Jul 11 16:37:22 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492545, encodeId=d516149254597, content=<a href='/topic/show?id=685199141a6' target=_blank style='color:#2F92EE;'>#静脉注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99141, encryptionId=685199141a6, topicName=静脉注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77e28942453, createdName=millore, createdTime=Tue May 31 13:37:22 CST 2022, time=2022-05-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2051793, encodeId=53922051e93a4, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Jan 09 23:37:22 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039840, encodeId=36fc20398405c, content=<a href='/topic/show?id=be04632e526' target=_blank style='color:#2F92EE;'>#正颌手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63275, encryptionId=be04632e526, topicName=正颌手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Jun 11 14:37:22 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698382, encodeId=aceb16983820d, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Dec 28 22:37:22 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020707, encodeId=bb182020e07df, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Mon Jul 11 16:37:22 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492545, encodeId=d516149254597, content=<a href='/topic/show?id=685199141a6' target=_blank style='color:#2F92EE;'>#静脉注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99141, encryptionId=685199141a6, topicName=静脉注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77e28942453, createdName=millore, createdTime=Tue May 31 13:37:22 CST 2022, time=2022-05-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2051793, encodeId=53922051e93a4, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Jan 09 23:37:22 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039840, encodeId=36fc20398405c, content=<a href='/topic/show?id=be04632e526' target=_blank style='color:#2F92EE;'>#正颌手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63275, encryptionId=be04632e526, topicName=正颌手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Jun 11 14:37:22 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698382, encodeId=aceb16983820d, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Dec 28 22:37:22 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020707, encodeId=bb182020e07df, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Mon Jul 11 16:37:22 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492545, encodeId=d516149254597, content=<a href='/topic/show?id=685199141a6' target=_blank style='color:#2F92EE;'>#静脉注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99141, encryptionId=685199141a6, topicName=静脉注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77e28942453, createdName=millore, createdTime=Tue May 31 13:37:22 CST 2022, time=2022-05-31, status=1, ipAttribution=)]
    2022-12-28 fusion
  4. [GetPortalCommentsPageByObjectIdResponse(id=2051793, encodeId=53922051e93a4, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Jan 09 23:37:22 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039840, encodeId=36fc20398405c, content=<a href='/topic/show?id=be04632e526' target=_blank style='color:#2F92EE;'>#正颌手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63275, encryptionId=be04632e526, topicName=正颌手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Jun 11 14:37:22 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698382, encodeId=aceb16983820d, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Dec 28 22:37:22 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020707, encodeId=bb182020e07df, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Mon Jul 11 16:37:22 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492545, encodeId=d516149254597, content=<a href='/topic/show?id=685199141a6' target=_blank style='color:#2F92EE;'>#静脉注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99141, encryptionId=685199141a6, topicName=静脉注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77e28942453, createdName=millore, createdTime=Tue May 31 13:37:22 CST 2022, time=2022-05-31, status=1, ipAttribution=)]
    2022-07-11 小几洁
  5. [GetPortalCommentsPageByObjectIdResponse(id=2051793, encodeId=53922051e93a4, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Mon Jan 09 23:37:22 CST 2023, time=2023-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2039840, encodeId=36fc20398405c, content=<a href='/topic/show?id=be04632e526' target=_blank style='color:#2F92EE;'>#正颌手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63275, encryptionId=be04632e526, topicName=正颌手术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=bugit, createdTime=Sat Jun 11 14:37:22 CST 2022, time=2022-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698382, encodeId=aceb16983820d, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Dec 28 22:37:22 CST 2022, time=2022-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2020707, encodeId=bb182020e07df, content=<a href='/topic/show?id=1584134451c' target=_blank style='color:#2F92EE;'>#Oral#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13445, encryptionId=1584134451c, topicName=Oral)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpeueeYB1kem1yfEZrSYKBdZBoqac9USf0RxIgRICBIyDn4licyiaiakNnobeCDVpvwqaWgwTNeLRHA/132, createdBy=bb5e2500127, createdName=小几洁, createdTime=Mon Jul 11 16:37:22 CST 2022, time=2022-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492545, encodeId=d516149254597, content=<a href='/topic/show?id=685199141a6' target=_blank style='color:#2F92EE;'>#静脉注射#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99141, encryptionId=685199141a6, topicName=静脉注射)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77e28942453, createdName=millore, createdTime=Tue May 31 13:37:22 CST 2022, time=2022-05-31, status=1, ipAttribution=)]

相关资讯

JAMA Pediatr:布洛芬对持续性动脉导管未闭早产儿支气管肺发育不良风险的影响

总体上,布洛芬在降低持续性动脉导管未闭早产儿支气管肺发育不良和死亡率方面无显著优势,但对于23-26周早产儿布洛芬治疗具有一定的效果。

Pan Afr Med J:在治疗五岁以下儿童的发烧方面,布洛芬与扑热息痛更有效

大多数儿童疾病都伴有发烧症状,常用的退烧药是布洛芬和扑热息痛。大多数关于布洛芬和扑热息痛治疗五岁以下儿童发烧的有效性的研究是在欧洲和北美进行的,在非洲儿童中进行的研究非常少。近日,研究人员在尼日利亚卡

J Endod:体内评估术前布洛芬对不可逆牙髓炎促炎症因子的影响

这篇研究的目的是为了比较罹患不可逆牙髓炎患者术前给予布洛芬后牙髓中促炎症因子的水平与未给予药物患者之间的差异。

J Matern Fetal Neonatal Med:口服扑热息痛VS口服布洛芬治疗早产儿动脉导管未闭的疗效和安全性

本研究旨在评价口服扑热息痛与口服布洛芬治疗早产儿动脉导管未闭(hsPDA)的疗效和安全性,研究结果已在线发表于J Matern Fetal Neonatal Med。

EHJCP:塞来昔布与萘普生或布洛芬治疗关节炎的心肾风险比较

非甾体抗炎药是全世界最常用的止痛药,在关节炎患者中的长期心血管安全性引起了争议,本文旨在进一步在PRECISH试验中测试的三种非类固醇抗炎药的心肾安全性。

中国超过5万名儿童研究,布洛芬可显著增加急性肾损伤风险!

布洛芬是一种非甾体类抗炎药(NSAID),是一种非选择性的环氧合酶阻滞剂。

Baidu
map
Baidu
map
Baidu
map